Project Grant HT94252310521
Award Date 7/1/23
Completion Date 6/30/26
Dollars Obligated $248K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43210, USA
Similar Awards
- The Defense Health Agency awarded a $512,751.00 Project Grant to The Ohio State University for the period from July 1, 2023 to June 30, 2026. The grant was provided under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for Service Members and the American public through innovative and impactful research, and to investigate medical solutions for the battlefield. The grant funds will...
- This federal Project Grant award for $7,700,740.00 was made by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Ohio State University. The funding supports a 4-year research project titled "CONSEQUENCES OF BRAIN INJURY ON GLIA-NEURON DYNAMICS, NEUROPATHOLOGY, AND NEUROPSYCHIATRIC ILLNESS" aimed at investigating the effects of brain injury on glial-neuronal interactions, neuropathology, and neuropsychiatric conditions. The...
- The U.S. Defense Health Agency awarded The Ohio State University a $1,479,970 Project Grant on July 15, 2025 under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "PRESERVING VISION AFTER NEUROTRAUMA (PREVANT)," will fund advanced biomedical research aimed at developing innovative medical solutions to address critical health challenges relevant to military personnel and the broader public. The research conducted under this grant will...
- This federal Project Grant award of $267,311 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a randomized clinical trial utilizing crisis response planning for suicide prevention in military personnel with traumatic brain injury. The award was made to The Ohio State University, which will serve as the prime recipient, with a performance period from August 1, 2024 to July 31, 2027. The project aims to...
- This $2,976,672 federal Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by The Ohio State University to examine the efficacy of short-term intensive PTSD treatment on psychological and cognitive impairment symptoms. The research project, which runs from September 1, 2025 to August 31, 2029, aims to develop innovative medical solutions to address critical health challenges relevant to military...
- This $249,960 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Ohio State University to investigate the effects of the aged inflammatory central nervous system (CNS) microenvironment on oligodendroglial properties and remyelination capacity. The research aims to advance scientific understanding of age-related changes in the CNS that can impact myelin repair, with potential applications for...
- The Ohio State University has been awarded a $5,009,418.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop "The Core Competency Model-Military Version (CCM-MV): A Virtual Suicide Prevention Training Program". The award, which commences on September 1, 2025 and has an ultimate completion date of August 31, 2029, will fund the creation of a virtual suicide prevention training program for...
- The federal Project Grant award of $1,225,245.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research initiative titled "CARDIOVASCULAR RISK PROFILING OF DEPLOYMENT-RELATED RESPIRATORY DISEASE: A TRANSLATIONAL APPROACH" at The Ohio State University. The research project aims to investigate cardiovascular risk factors associated with deployment-related respiratory diseases, with the goal of developing...
- This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,181,250.00 to The Ohio State University to conduct research on the use of MIF inhibition and glucocorticoid therapeutics as a synergistic treatment to promote neuronal survival in traumatic retinal injury. The research aims to develop novel therapies for this type of injury, which is of particular relevance to military personnel. The...
- The Department of Defense's Defense Health Agency awarded a $1,158,179.00 Project Grant to The Ohio State University under the Military Medical Research and Development program (CFDA 12.420) to deliver a sustained therapeutic protein cocktail delivery system to prevent vision loss after ocular trauma. The project aims to develop innovative treatments for military service members and veterans by conducting basic, translational, and clinical research. As a sub-award under this grant, the...